A Phase 4 interventional study of Anticoagulation clinic and Standard anticoagulation care in Cardiopathy, Chagas Disease and Hemorrhage, sponsored by Federal University of Minas Gerais. Completed at 1 site in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-10-25.
Sponsored by Federal University of Minas Gerais · Phase 4, Interventional, and Health services research
A clinical trial designed to compare the oral anticoagulation control obtained by an anticoagulation clinic and the usual medical care in Chagas and Non-Chagas disease patients.
A Randomized, Crossover, Clinical Trial performed to compare the results of oral anticoagulation for Chagas and non-Chagas disease patients treated at an anticoagulation clinic and by the usual clinical practice. The primary endpoint was the time that the International Normalized Ratio (INR) was in the therapeutic range and the secondary endpoints were thromboembolic/haemorragic events.
68 studies on the registry are indexed under Chagas Disease; 4 are open to participants now.
This study's enrollment of 280 is above the median of 87 across 45 interventional studies indexed under Chagas Disease.
Browse Chagas Disease studies →Federal University of Minas Gerais is the lead sponsor of 150 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Anticoagulation clinic, including all procedures related to a standardized use of coumarins.
Other: Anticoagulation clinic
Standard use of coumarins, as prescribed by their physicians.
Other: Standard anticoagulation care
Patients randomized to this arm will be cared at an anticoagulation clinic, with educational measures and standardized procedures related to the use of coumarins.
Also known as: Implementation of a health service
Patients randomized to this arm will be cared by their physician, with standard care. No standardized protocol of the use of coumarins will be established.
Also known as: Implementation of a health service
Time in therapeutic range
Time frame: 1 year
Hemorrhagic events
Time frame: 1 year
Thromboembolic events
Time frame: 1 year
This study is completed, as verified in Oct 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Federal University of Minas Gerais